by Alexandre Deballe | Jul 23, 2025 | Investment Analysis
Ticker : DEFTSector : TechnologyMarket Cap : $1.05BStock Price : $3.18 Introduction – Crypto’s Regulatory Turning Point This past week marked a watershed moment in crypto policy. For investors, founders, and users of decentralized finance, the intersection of...
by Alexandre Deballe | Jul 22, 2025 | Investment Analysis
Ticker : SL.MI (Sanlorenzo S.p.A.) – Bourse de MilanSecteur : Luxe – Construction navale haut de gammeCapitalisation boursière : ~€900MStock Price : €29.5 Introduction – Why Sanlorenzo Deserves Investor Attention Sanlorenzo is one of the best-kept secrets...
by Alexandre Deballe | Jul 21, 2025 | Investment Analysis
Ticker: $SRPTSector: Biotech – Gene TherapyMarket Cap: ~$4.7BPrice (July 2025): ~$14.08 Sarepta Therapeutics (SRPT): Gene Therapy Momentum Fueling Rerating? As of July 2025, Sarepta Therapeutics (NASDAQ: SRPT) is up approximately +25% year-to-date,...
by Alexandre Deballe | Jul 18, 2025 | Investment Analysis
Introduction: Why Is Vor Biopharma Back on Investors’ Radars? Vor Biopharma, once considered an overlooked small-cap biotech, is making a noticeable comeback in 2025. Following a challenging period marked by clinical setbacks and internal restructuring, the company is...
by Alexandre Deballe | Jul 17, 2025 | Investment Analysis
Introduction: Why Zeta Is on Investors’ Radars In today’s market, it is rare to find a company that is delivering standout financial results while its stock price tells a completely different story. This is the exact situation with Zeta Global (ticker: ZETA),...
